Home / Business and Economy / Protein Craze: Consumers Scrutinize Health Claims
Protein Craze: Consumers Scrutinize Health Claims
23 Oct
Summary
- GLP-1 drug users increase high-protein food spending.
- Consumers question accuracy of protein content claims.
- Brands face scrutiny over serving sizes and additives.
The widespread use of weight-loss drugs such as Ozempic and Mounjaro has significantly boosted the market for protein-infused foods and beverages, from bottled water to vodka. Users of these GLP-1 medications indicate a heightened willingness to spend more on high-protein options to mitigate potential muscle loss associated with the drugs. This surge in demand, however, is met with increasing consumer skepticism regarding the accuracy of protein content advertised on product labels. Many shoppers are scrutinizing claims, particularly when products contain excessive additives or sugar that undermine their health appeal.
The snack industry, in particular, is entering an "accountability era," with a notable rise in consumers using scanning apps to verify nutritional information. Experts note that 'protein' is no longer a unique selling point, compelling brands to offer more than just a high gram count. Companies are now focusing on the quality of protein sources, nutrient density, and digestibility, with some even engaging in legal disputes over competitors' labeling practices. Despite these concerns, the market for protein-enriched foods was valued at nearly $58 billion last year, and retailers are expanding their offerings to meet sustained consumer interest.
